NFE2L2 and Alzheimer disease: To delve deeper into the protective role of EVOO consumption in AD concerning NRF2, we compared the molecular mechanisms and biological processes (BPs) involving EVOO’s differentially expressed genes (DEGs) with NRF2-related AD DEGs and with the functional terms targeted by clinical trial drugs for AD with NRF2 activation ability or drugs used to treat other diseases.